A dual-targeting anticancer approach: soil and seed principle

Area of Science:

• Oncology
• Radiochemistry
• Pharmacology

Background:

• Cancer treatment often faces challenges with drug delivery and efficacy.
• Targeting the tumor microenvironment is an emerging strategy in cancer therapy.
• Theranostic approaches combine diagnosis and therapy for improved outcomes.

Purpose of the Study:

• To evaluate a sequential dual-targeting theragnostic strategy for cancer treatment.
• To test the hypothesis that targeting the tumor microenvironment can eliminate cancer cells.
• To assess a novel approach using a vascular-disrupting agent and a necrosis-avid radioisotope.

Main Methods:

• Rats with liver rhabdomyosarcomas were treated with combretastatin A4 phosphate (CA4P) to induce necrosis.
• Hypericin was radiolabeled with iodine 131 ((131)I-hypericin) and administered 24 hours after CA4P.
• Tumor response was assessed using in vivo imaging and ex vivo analyses, comparing dual-targeting with single-targeting and control groups.

Main Results:

• The dual-targeting group showed a significant reduction in tumor volume compared to single-targeting and control groups.
• Tumor doubling time was significantly longer in the dual-targeting group, indicating inhibited regrowth.
• (131)I-hypericin accumulated in CA4P-induced necrosis, delivering a dose sufficient for radiotherapeutic response and killing residual cancer cells.

Conclusions:

• The sequential dual-targeting theragnostic strategy is a simple and workable solution for cancer treatment.
• This approach effectively targets and eliminates cancer cells by exploiting the tumor microenvironment.
• Further research and exploitation of this dual-targeting strategy are warranted.